Interferon gamma release assays: principles and practice.
about
Current developments and future perspectives for TB diagnostics.Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.Concordance of the tuberculin skin test and T-SPOT(®).TB test results in kidney transplant candidatesRisk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis.Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin testEvaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populationsAgreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.Mycobacterium tuberculosis infection is associated with the development of erythema nodosum and nodular vasculitis.Diagnostic performance of interferon-gamma releasing assay in HIV-infected patients in China.Mycobacterial skin and soft tissue infection.Diagnostic value of T-SPOT.TB interferon-γ release assays for active tuberculosis.Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma modelComparison of the interferon-gamma release assay with the traditional methods for detecting Mycobacterium tuberculosis infection in childrenRapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs)HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.Advances in the Diagnosis, Treatment and Control of HIV Associated TuberculosisDried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paperMyopericarditis and severe myocardial dysfunction as the initial manifestation of systemic lupus erythematosusSignificant reduction in rate of indeterminate results of the QuantiFERON-TB Gold In-Tube test by shortening incubation delay.Latent tuberculosis: what the host "sees"?Redefining latent tuberculosis.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.The role of interferon-gamma release assay in tuberculosis control.The history and evolution of immigration medical screening for tuberculosis.Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.Mycobacterium diagnostics: from the primitive to the promising.Diagnosis of Ocular Tuberculosis.Reconfigurable microfluidics combined with antibody microarrays for enhanced detection of T-cell secreted cytokines.Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma.Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study.Application of molecular, microbiological, and immunological tests for the diagnosis of bone and joint tuberculosis.Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country.Association of clinical properties and compatibility of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test in patients with psoriasis.Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence.
P2860
Q30410962-E6ED07FF-5C9F-4EF4-B1EE-96AC7F68BF8DQ33599396-738426A4-1CF8-46BE-BD95-7D6F509EF1E4Q33640495-DB25BB16-21D5-4837-9A80-73240C4ABE65Q33825672-E7BE5508-89E2-4F8A-B395-2DD91A1735B5Q33833222-BB7AEFBD-70B5-4C6E-A99D-56E804EDCFB2Q33869437-9125D91B-F156-4239-982A-D5A87D85DDBEQ34128381-4039D920-CB06-4E24-8518-F72502867037Q34199932-F36069BE-3DCB-4827-AA0E-9299D9CAB301Q34290538-DEAE2636-0412-49C7-874D-FB5D5BC4BAE0Q34360363-E4062AC1-6DCA-4A1C-B1F1-49992C098322Q34432005-8508E549-6603-4196-A6B8-B93B75A54560Q34486077-3922ABFB-F5E8-4B06-A262-379DBAE2755DQ34708408-B49A4AE7-87AF-46AB-BDA3-43EEE2BF2C8FQ34926355-922EAE94-00CB-4892-B64B-CFE80246931CQ35359858-5D78D10F-56EF-487D-A3FD-B789D555E0B5Q35802723-5CEE4D59-D462-44D8-9BDB-784C740230A6Q36092291-0133E073-7773-49FE-8185-EEF983C10447Q36193426-249D16B5-934D-4F98-AB72-0E9FFF7462C2Q36375791-D347139B-FE9B-47AF-8A3A-138D4C462D95Q36378669-F8B9FAE4-EDEF-46C9-8D1A-57624C8B8D15Q36627619-495D8044-D170-4780-B371-165D688967EDQ37060835-08DB22EC-738A-402E-AB4D-E690CF582189Q37140931-E0B05184-D8C5-4323-AAF5-6F09684173E8Q37546805-2413CBDE-EDAD-4E13-9863-F03657E55058Q37895957-807D1BF9-9C6F-47B0-A6A0-790C89D1B52FQ37940571-ECD1720F-507B-41B5-A474-D59486EB5210Q37988577-56F2A9C5-0414-4A4B-94A8-2DBC39B74D0FQ37997253-D9C2B0F6-07DF-407B-8BBB-817CE39761BDQ38081493-EA9263F6-8EFD-461B-ABA6-C944C2517E0FQ38346475-CADC8F68-9820-4167-B276-73D2D9475E6BQ38438695-1373ACF7-DED0-4D87-BA6C-ADFDC12597E5Q38886299-FD216ED1-CB77-4EA2-997E-9574DF77F6AFQ39436232-69214E16-3322-41E7-9A4B-613463FBF25DQ39438318-1AC215C8-41B6-49F7-8237-70B5598C3DFBQ39525399-60E1C60E-2956-4BA9-99BC-01F7DF665E3BQ39713866-68B57868-1B58-45F7-B067-6B562159D5C6Q40198824-19065C6E-0261-4D67-8A2F-9EEF7245AA58Q40931904-31F8F40C-FC96-477D-97F6-3C8E2C6E8768Q40938299-E8707CF3-1EA0-4F63-96C7-423B4B600848Q41101922-413DA1E5-B122-478C-ADF4-C27A73844C8D
P2860
Interferon gamma release assays: principles and practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon gamma release assays: principles and practice.
@en
Interferon gamma release assays: principles and practice.
@nl
type
label
Interferon gamma release assays: principles and practice.
@en
Interferon gamma release assays: principles and practice.
@nl
prefLabel
Interferon gamma release assays: principles and practice.
@en
Interferon gamma release assays: principles and practice.
@nl
P1476
Interferon gamma release assays: principles and practice.
@en
P2093
Manish Pareek
P304
P356
10.1016/J.EIMC.2009.05.012
P50
P577
2009-09-24T00:00:00Z